This is a Boston news story, published by Yahoo, that relates primarily to Cabometyx news.
For more Boston news, you can click here:
more Boston newsFor more Cabometyx news, you can click here:
more Cabometyx newsFor more longevity news, you can click here:
more longevity newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about longevity, you might also like this article about
aged eggs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Older eggs news, egg matures news, news about longevity, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
assisted reproduction therapiesReuters
•79% Informative
Study suggests it might someday be possible to "rejuvenate" eggs from older women in order to make them suitable for assisted reproduction therapies.
The other suggests there may someday be a way to prevent serious cases of jaundice in newborns.
We also highlight a study with encouraging data for patients with advanced neuroendocrine tumors.
Exelixis drug helps in advanced form of pancreatic cancer.
"The results support the use of ( Cabometyx ) as a new treatment option for patients with advanced extrapancreatic neuroendocrine tumors or pancreatic neuroendocrine tumors whose disease has progressed after at least one other line of therapy.. or in whom unacceptable side effects have developed after such therapy," Dr. Jennifer Chan of the Dana-Farber Cancer Institute in Boston and colleagues wrote in the New England Journal of Medicine . (Reporting by Nancy Lapid ; editing by Will Dunham ).
VR Score
90
Informative language
97
Neutral language
46
Article tone
informal
Language
English
Language complexity
65
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links